Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |